URISPAS SKF (Urispas 100 mg)
Generic Name: flavoxate
Pill with imprint URISPAS SKF is White, Round and has been identified as Urispas 100 mg. It is supplied by GlaxoSmithKline.
Urispas is used in the treatment of dysuria; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Urispas 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for URISPAS SKF
Urispas
- Generic Name:
- flavoxate
- Imprint:
- URISPAS SKF
- Strength:
- 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-5290
More about Urispas (flavoxate)
- Urispas Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: urinary antispasmodics
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
